Insular component as a risk factor of thyroid carcinoma

Area of Science:

• Endocrinology
• Oncology
• Pathology

Background:

• Thyroid carcinomas (TC), including papillary (PC) and follicular carcinoma (FC), are common endocrine malignancies.
• The presence of an insular component (IC) within these tumors is a recognized, yet not fully understood, histological feature.
• Understanding the prognostic significance of IC in PC and FC is crucial for patient management and treatment strategies.

Purpose of the Study:

• To investigate the clinicopathological characteristics of thyroid carcinomas with an insular component (IC).
• To determine the prognostic value of the insular component in papillary (PC) and follicular carcinoma (FC).
• To identify independent prognostic factors associated with improved or diminished patient outcomes in these TC subtypes.

Main Methods:

• Retrospective review of 44 thyroid carcinomas exhibiting an insular component (IC) from a larger cohort of 2457 PC and FC cases.
• Classification of tumors into FC with IC (FCIC) and PC with IC (PCIC) based on histological features and nuclear characteristics.
• Univariate and multivariate analyses of 13 clinicopathological factors to assess their impact on patient prognosis.

Main Results:

• The study identified 30 FCIC and 14 PCIC cases, noting distinct nuclear sizes and larger tumor diameters in FCIC.
• Key independent prognostic variables identified included the presence of IC, patient age, non-encapsulation, tumor size, vascular invasion, and necrosis.
• A significant proportion of patients (17/44) died of the disease, underscoring the aggressive nature of tumors with IC.

Conclusions:

• The presence of an insular component (IC) is an independent aggressive prognostic factor in both papillary (PC) and follicular carcinoma (FC).
• Histopathological features like IC, alongside clinicopathological factors, are critical for predicting outcomes in thyroid cancer patients.
• Further research into the biological mechanisms underlying the aggressive behavior of IC in thyroid carcinomas is warranted.